Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of pleural effusions.

R W Light1

  • 1Saint Thomas Hospital, Vanderbilt University, Nashville, TN 37027, USA.

Journal of the Formosan Medical Association = Taiwan Yi Zhi
|August 5, 2000
PubMed
Summary

This review outlines the best practices for diagnosing and managing pleural effusions. It explains how to distinguish between transudative and exudative effusions using Light's criteria. Transudative effusions are treated by addressing the underlying cause, such as heart failure or cirrhosis. Exudative effusions require identifying the specific cause, such as infection or cancer. Pleural fluid cytology is the most effective way to detect malignancy, and thoracoscopy is recommended when results are unclear. The review also discusses the use of adenosine deaminase and gamma-interferon in diagnosing tuberculosis. For complex cases, intrapleural thrombolytic therapy may be used if fluid cannot be drained. Tetracycline derivatives are preferred for pleurodesis due to the risks associated with talc. The goal is to guide clinicians in selecting the most appropriate treatment based on the type and cause of the effusion.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful factor XIII treatment of refractory chylothorax in tuberous sclerosis complex-associated lymphangioleiomyomatosis, multifocal multinodular pneumocyte hyperplasia and mediastinal lymphadenopathy.

Lymphology·2018
Same author

Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count).

Canadian respiratory journal·2017
Same author

Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio).

Lung·2015
Same author

Research: Why and how to write a paper?

Revista clinica espanola·2015
Same author

Comparison of polymorphonuclear- and lymphocyte-rich tuberculous pleural effusions.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2012
Same author

Drug-induced eosinophilic pleural effusion.

European respiratory review : an official journal of the European Respiratory Society·2011

Area of Science:

  • Pulmonary and respiratory medicine
  • Diagnostic imaging and procedures
  • Thoracic surgery

Background:

Managing pleural effusions requires distinguishing between transudative and exudative types. Prior research has shown that Light's criteria are essential for classification. However, gaps remain in defining optimal treatment for recurrent or malignant effusions. No prior work had resolved the best approach for patients with loculated fluid or those at risk of respiratory distress from pleurodesis. This uncertainty drove the need for a comprehensive review of current diagnostic and therapeutic strategies. The literature has not fully addressed the comparative effectiveness of thoracoscopy versus thoracotomy in complex cases. Additionally, the role of adenosine deaminase and gamma-interferon in diagnosing tuberculosis remains underexplored in clinical settings. This paper's contribution lies in synthesizing evidence on treatment pathways based on effusion type and underlying pathology. The review also clarifies when to use thrombolytic therapy and the risks associated with talc-based pleurodesis.

Purpose Of The Study:

Keywords:
pleural effusion diagnosispleurodesis procedurethoracoscopy usepleural fluid analysis

Frequently Asked Questions

Transudative effusions are managed by treating the underlying condition, while exudative effusions require identifying and addressing the specific cause, such as infection or malignancy.

Thoracoscopy is indicated when pleural fluid cytology is negative but malignancy is suspected, allowing direct visualization and biopsy of the pleura.

Talc induces acute respiratory distress syndrome in about 5% of patients and has an overall mortality rate of 1%, making it a high-risk option.

Poor prognosis is indicated by frank pus, low glucose (<2.2 mmol/L), low pH (<7.00), and high LDH levels in pleural fluid.

Related Experiment Videos

This review aims to clarify the best practices for diagnosing and managing pleural effusions. It focuses on the clinical decision-making process for transudative versus exudative effusions. The study addresses the limitations of current diagnostic tools and treatment options. It seeks to guide clinicians in selecting appropriate interventions based on effusion characteristics. The authors aim to highlight the importance of thoracoscopy in diagnosing malignancy when cytology is negative. The review also evaluates the risks and benefits of various pleurodesis agents. It emphasizes the need for tailored treatment based on the underlying cause of the effusion. The ultimate goal is to improve patient outcomes by reducing complications and guiding therapeutic choices.

Main Methods:

The authors conducted a systematic review of current literature on pleural effusion management. They analyzed clinical guidelines and diagnostic criteria used in practice. Light's criteria were evaluated for their accuracy in classifying effusion types. The review included studies on pleurodesis agents and their associated risks. Thoracoscopy and thoracotomy were compared for diagnostic and therapeutic purposes. The role of adenosine deaminase and gamma-interferon in diagnosing tuberculosis was examined. The study assessed outcomes of intrapleural thrombolytic therapy in loculated effusions. The authors synthesized evidence from multiple sources to present a structured management approach.

Main Results:

Light's criteria remain the standard for distinguishing transudative from exudative effusions. Transudative effusions require treatment of the underlying condition, such as heart failure or cirrhosis. Recurrent transudative effusions may benefit from pleurodesis with a sclerosant. Exudative effusions demand identification of the cause, such as malignancy or infection. Pleural fluid cytology is the most effective method for diagnosing malignancy. Thoracoscopy is recommended when cytology is negative but malignancy is suspected. Adenosine deaminase and gamma-interferon levels are useful in diagnosing tuberculosis. Patients with parapneumonic effusions should undergo thoracentesis and fluid analysis.

Conclusions:

The authors propose that accurate classification using Light's criteria is essential for guiding treatment. Transudative effusions require addressing the underlying systemic condition. Recurrent cases may benefit from pleurodesis with a sclerosant. Exudative effusions demand a diagnostic workup to identify the cause. Thoracoscopy is indicated when malignancy is suspected despite negative cytology. Thrombolytic therapy is recommended for loculated effusions that resist drainage. Tetracycline derivatives are preferred over talc for pleurodesis due to the risk of respiratory distress. The review emphasizes the importance of individualized treatment based on diagnostic findings.

Thrombolytic therapy is considered when pleural fluid cannot be fully drained due to loculations and standard drainage is ineffective.

Tetracycline derivatives are preferred over talc for pleurodesis in malignant effusions due to the lower risk of respiratory complications.